| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012100225 |
| P356 | DOI | 10.1186/AR3693 |
| P932 | PMC publication ID | 3392804 |
| P698 | PubMed publication ID | 22264405 |
| P5875 | ResearchGate publication ID | 221765756 |
| P2093 | author name string | William H Robinson | |
| Soon-Suk Kang | |||
| Bongkun Choi | |||
| Yeon-Ho Chung | |||
| Chang-Keun Lee | |||
| Jae-Ho Chang | |||
| Yong-Gil Kim | |||
| Eun-Ju Chang | |||
| Seung-Jun Hwang | |||
| Min Wook So | |||
| Dong Hyun Sohn | |||
| P2860 | cites work | Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood | Q24299211 |
| Discovery of a cytokine and its receptor by functional screening of the extracellular proteome | Q24310846 | ||
| Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells | Q24315662 | ||
| Vascular endothelial growth factor receptors in osteoclast differentiation and function | Q81073512 | ||
| Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts | Q83011634 | ||
| Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis | Q24792470 | ||
| Tumour necrosis factor-alpha stimulates dehydroepiandrosterone metabolism in human fibroblast-like synoviocytes: a role for nuclear factor-kappaB and activator protein-1 in the regulation of expression of cytochrome p450 enzyme 7b | Q24812796 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis | Q28202653 | ||
| Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 | ||
| Cytokines in the pathogenesis of rheumatoid arthritis | Q28303865 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells | Q33803260 | ||
| The critical role of IL-34 in osteoclastogenesis | Q33873578 | ||
| c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis | Q33873745 | ||
| M-CSF mediates TNF-induced inflammatory osteolysis | Q34133595 | ||
| Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis | Q34967810 | ||
| Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha | Q35553437 | ||
| Synovial fibroblasts: key players in rheumatoid arthritis | Q36433286 | ||
| TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood | Q36757010 | ||
| Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs | Q36897036 | ||
| TNF-mediated inflammatory disease. | Q37045764 | ||
| Review: Immune cells and mediators of inflammatory arthritis | Q37118782 | ||
| Colony-stimulating factors in inflammation and autoimmunity. | Q37190439 | ||
| A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations | Q40249893 | ||
| Cytokines, growth factors and osteoclasts | Q41759291 | ||
| Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption | Q41772601 | ||
| Production of macrophage colony-stimulating factor (M-CSF) by human articular cartilage and chondrocytes. Modulation by interleukin-1 and tumor necrosis factor alpha. | Q42506327 | ||
| IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. | Q43057759 | ||
| Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis | Q43146568 | ||
| Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes | Q43180966 | ||
| A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study | Q45246613 | ||
| IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. | Q46372900 | ||
| Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. | Q48340042 | ||
| Rheumatoid arthritis | Q56656479 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Regulation of macrophage colony-stimulating factor (M-CSF) production in cultured human synovial fibroblasts | Q72549297 | ||
| Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation | Q73100858 | ||
| The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF | Q74066265 | ||
| Nuclear factor-kappaB p50 is required for tumor necrosis factor-alpha-induced colony-stimulating factor-1 gene expression in osteoblasts | Q74086425 | ||
| Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters | Q77424486 | ||
| Hepatocyte growth factor can substitute for M-CSF to support osteoclastogenesis | Q79193387 | ||
| Autoimmunity and bone | Q79872937 | ||
| Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation | Q80235660 | ||
| P433 | issue | 1 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| human fibroblast | Q101404861 | ||
| P304 | page(s) | R14 | |
| P577 | publication date | 2012-01-20 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis | |
| P478 | volume | 14 |
| Q48150940 | 1α,25-Dihydroxyvitamin D3 up-regulates IL-34 expression in SH-SY5Y neural cells |
| Q39029629 | A review on interleukins: The key manipulators in rheumatoid arthritis |
| Q64230245 | A role for IL-34 in osteolytic disease of multiple myeloma |
| Q50748716 | AG490 suppresses interleukin-34-mediated osteoclastogenesis in mice bone marrow macrophages. |
| Q38679771 | Amphibian macrophage development and antiviral defenses |
| Q87401233 | Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis |
| Q47800990 | Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications. |
| Q58774487 | Bone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications |
| Q54369171 | Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis. |
| Q33653719 | CSF-1 receptor signaling in myeloid cells |
| Q27022559 | Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis |
| Q28601432 | Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis |
| Q92135098 | Comparative evaluation of Gingival Crevicular Fluid (GCF) levels of Interleukin-34 levels in periodontally healthy and in patients with chronic and aggressive periodontitis- A cross-sectional study |
| Q34456715 | Cytokine-modulating strategies and newer cytokine targets for arthritis therapy |
| Q92464580 | Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets |
| Q34484106 | Divergent antiviral roles of amphibian (Xenopus laevis) macrophages elicited by colony-stimulating factor-1 and interleukin-34. |
| Q98180487 | Drainage of inflammatory macromolecules from brain to periphery targets the liver for macrophage infiltration |
| Q37660315 | Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function |
| Q38934355 | Functions of interleukin-34 and its emerging association with rheumatoid arthritis |
| Q43050400 | IL-1β and TNFα promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblasts |
| Q42428609 | IL-34 Suppresses Candida albicans Induced TNFα Production in M1 Macrophages by Downregulating Expression of Dectin-1 and TLR2. |
| Q33808899 | IL-34 Upregulated Th17 Production through Increased IL-6 Expression by Rheumatoid Fibroblast-Like Synoviocytes |
| Q38112353 | IL-34 and CSF-1: similarities and differences |
| Q24317213 | IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγ |
| Q90115343 | Immunomodulation of Interleukin-34 and its Potential Significance as a Disease Biomarker and Therapeutic Target |
| Q39160565 | Immunoregulatory properties of the cytokine IL-34. |
| Q38694818 | Increased IL-6 expression on THP-1 by IL-34 stimulation up-regulated rheumatoid arthritis Th17 cells |
| Q38218977 | Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis |
| Q92107521 | Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview |
| Q34599064 | Integrative genomic analyses of a novel cytokine, interleukin-34 and its potential role in cancer prediction |
| Q38204948 | Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells |
| Q90681297 | Interleukin 34 (IL-34) cell-surface localization regulated by the molecular chaperone 78-kDa glucose-regulated protein facilitates the differentiation of monocytic cells |
| Q54976880 | Interleukin-34 Regulates Th1 and Th17 Cytokine Production by Activating Multiple Signaling Pathways through CSF-1R in Chicken Cell Lines. |
| Q58787765 | Interleukin-34 Synovial Fluid Was Associated with Knee Osteoarthritis Severity: A Cross-Sectional Study in Knee Osteoarthritis Patients in Different Radiographic Stages |
| Q35870921 | Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy. |
| Q41052789 | Interleukin-34 induces monocytic-like differentiation in leukemia cell lines. |
| Q94686824 | Interleukin-34 overexpression mediated through tumor necrosis factor-alpha reflects severity of synovitis in knee osteoarthritis |
| Q54282841 | Interleukin-34 sustains inflammatory pathways in the gut. |
| Q38576851 | Mediators of inflammation and bone remodeling in rheumatic disease |
| Q98465934 | Molecular mechanisms and clinical management of cancer bone metastasis |
| Q104576046 | Origins and diversity of macrophages in health and disease |
| Q35755039 | Osteoclasts: New Insights |
| Q38308220 | PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production |
| Q87339962 | Predictors of response to TNF-α antagonist therapy in Chinese rheumatoid arthritis |
| Q33820660 | Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor |
| Q55226585 | Regulation of Osteoclast Differentiation by Cytokine Networks. |
| Q36056520 | Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice |
| Q26823954 | Targeting IL-34 in chronic inflammation |
| Q53183275 | The cut-off value for interleukin 34 as an additional potential inflammatory biomarker for the prediction of the risk of diabetic complications. |
| Q38671481 | The dynamic evolution of rheumatology in Korea |
| Q35067581 | The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation |
| Q42768253 | Tumor necrosis factor-α induces interleukin-34 expression through nuclear factor‑κB activation in MC3T3-E1 osteoblastic cells |
| Q42715792 | p53 contributes to quercetin-induced apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes |
Search more.